ARCA Biopharma Inc ABIO:NASDAQ

Last Price$2.25NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/03/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$2.26 (6)
Ask (Size)$2.26 (1)
Day Low / HighN/A - N/A
Volume611.5 K
 

View Biotechnology IndustryPeer Comparison as of 12/03/2021

 

ARCA Biopharma Inc ( NASDAQ )

Price: $2.25
Change: 0.00 (0.00%)
Volume: 611.5 K
4:00PM ET 12/03/2021
 
 

Cyclacel Pharmaceuticals Inc ( NASDAQ )

Price: $3.24
Change: -0.24 (6.90%)
Volume: 69.4 K
4:00PM ET 12/03/2021
 
 

Brickell Biotech Inc ( NASDAQ )

Price: $0.28
Change: -0.006 (2.04%)
Volume: 1.3 M
4:00PM ET 12/03/2021
 
 

Alimera Sciences Inc ( NASDAQ )

Price: $4.63
Change: -0.27 (5.51%)
Volume: 47.3 K
4:00PM ET 12/03/2021
 
 

Forte Biosciences Inc ( NASDAQ )

Price: $2.24
Change: -0.18 (7.44%)
Volume: 446.9 K
4:00PM ET 12/03/2021
 

Read more news Recent News

-- Earnings Flash (ABIO) ARCA BIOPHARMA Reports Q3 Loss $-0.33
4:21PM ET 11/02/2021 MT Newswires

...

Sector Update: Health Care Stocks Muted in Lead Up to Friday's Opening Bell
9:02AM ET 10/29/2021 MT Newswires

Health care stocks were muted ahead of the opening bell on Friday. The Health Care SPDR (XLV) was flat while the iShares NASDAQ Biotechnology Index (IBB)...

Sector Update: Health Care
8:22AM ET 10/29/2021 MT Newswires

Health care stocks inched lower ahead of the opening bell on Friday. The Health Care SPDR (XLV) was down 0.1% while the iShares NASDAQ Biotechnology Index...

ARCA biopharma Enrolls First International Patient in Phase 2b Trial of rNAPc2 to Treat COVID-19
9:14AM ET 9/16/2021 MT Newswires

ARCA biopharma (ABIO) has enrolled the first international patient in a phase 2b clinical trial evaluating rNAPc2 as a potential treatment for patients...

View all Commentary and Analysis

Nuvo Group Begins U.S. IPO Effort
2:06PM ET 11/30/2021 Seeking Alpha

U.S. IPO Weekly Recap: The Shortened Holiday Week Brings Just 1 IPO
10:43PM ET 11/27/2021 Seeking Alpha

ARCA biopharma (ABIO) Investor Presentation - Slideshow
1:41PM ET 8/23/2021 Seeking Alpha

Company Profile

Business DescriptionARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on the cardiovascular pathophysiology, molecular genetics, and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO. View company web site for more details
Address10170 Church Ranch Way
Westminster, Colorado 80021
Phone+1.720.940.2200
Number of Employees15
Recent SEC Filing12/02/20218-K
President, Chief Executive Officer & DirectorMichael R. Bristow
Chief Operating OfficerThomas A. Keuer
Chief Financial OfficerC. Jeffrey Dekker
Chief Medical OfficerDebra Marshall

Company Highlights

Price Open$2.28
Previous Close$2.25
52 Week Range$2.17 - 5.50
Market Capitalization$32.4 M
Shares Outstanding14.4 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement03/17/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.53
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-32.61%

Analyst Ratings as of 11/11/2019

Buy
1
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset